Legal Representation
Attorney
Enshan Hong
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 10, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 10, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 4, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 8, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 8, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 8, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 8, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 8, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 26, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 26, 2024 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Sep 26, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Sep 26, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 26, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Sep 26, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 27, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Aug 27, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| May 6, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 6, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 6, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 27, 2023 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Sep 26, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 1, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmacological research utilizing biological technology based on structure-based probe design, chemical proteomics, and proteomics mass spectrometer to discover unliganded or undruggable targets from live cells, tissues, and live animals for the purpose of discovering new drugs and developing new drug therapeutics
First Use Anywhere:
Nov 9, 2018
First Use in Commerce:
Nov 9, 2018
Additional Information
Design Mark
The mark consists of stylized letters "B" and "G" overlapping with each other in a square with rounded corners, to the right of which are words "BRIDGENE BIOSCIENCES".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
BRIDGENE BIOSCIENCES BRIDGENE BIOSCIENCES BRIDGE GENE BIOSCIENCES
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"